uniQure N.V. (NASDAQ:QURE) traded at $24.64 at last check on Wednesday, November 23, made an upward move of 7.13% on its previous day’s price.
Looking at the stock we see that its previous close was $23.00 and the beta (5Y monthly) reads 0.99 with the day’s price range being $20.81 – $23.92. In terms of its 52-week price range, QURE has a high of $30.41 and a low of $12.52. The company’s stock has gained about 24.53% over that past 30 days.
uniQure N.V. has a market cap of $1.08 billion and is expected to release its quarterly earnings report on Feb 23, 2023 – Feb 27, 2023. Estimates by analysts give the company expected earnings per share (EPS) of -$1.16, with the EPS growth for the year raised at -$3.63 for 2022 and -$1.24 for next year. These figures represent -151.60% and 65.80% growth in EPS for the two years respectively.
The median projection represents growth squeezing down to 75.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $35.65 million, or -93.20% down from figures reported last year.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the QURE stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Based on estimates by 18 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the uniQure N.V. (QURE) stock as a Hold, while 16 rate it as a Buy. 1 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 21.31% off its SMA20 and 26.32% from its 50-day simple moving average. The RSI (14) is pointing at 70.39 while the volatility over the past week is 6.86% and jumps to 5.79% over the past one month. The beta value is 0.96, while the average true range (ATR) is currently pointing at 1.28. The average price target for the stock over the next 12 months is $51.13, with the estimates having a low of $24.00 and a high of $90.00. These price ends are 2.6% and -265.26% off the today’s price level respectively, although investors could be excited at the prospect of a -111.04% if the QURE share price touches on the median price of $52.00.
Let’s briefly compare uniQure N.V. (QURE) stock to its peers. We find that today’s price change of 7.13% and -20.19% over the past 12 months for QURE competes that of Sangamo Therapeutics Inc. (SGMO), which has seen its stock price rise 0.28% in the latest trading session and is -59.64% over the last one year. Another of its peers Ionis Pharmaceuticals Inc. (IONS) has dropped -0.47% today, and was 37.68% up over the past year, while Sanofi (SNY) is also down -0.64% yet, while its price remains in the red at -9.36% over the same period. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 0.51% and 0.24%, respectively, in early deals.
Coming back to uniQure N.V. (NASDAQ:QURE), we note that the average 3-month trading volume was 601.15K, while that of the preceding 10-day period stands at 0.67 million. Current shares outstanding are 46.77 million.
The insiders hold 0.90% of the company’s shares while institutions hold 92.20%. The data shows that short shares as of Oct 13, 2022, stood at 3.0 million at a short ratio of 4.68. This represents a 6.42% short interest in shares outstanding on Oct 13, 2022. Shares short rose in October from the previous month at 2.96 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 10.90% up in year-to-date price movement.